Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;28(1):47-54.
doi: 10.5625/lar.2012.28.1.47. Epub 2012 Mar 21.

Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats

Seunghoon Lee  1 , Jinhee Shin, Yunkyung Hong, Minkyung Lee, Koo Kim, Sang-Rae Lee, Kyu-Tae Chang, Yonggeun Hong
Affiliations

Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats

Seunghoon Lee et al. Lab Anim Res. 2012 Mar.

Abstract

MUSCLE ATROPHY IS THE RESULT OF TWO OPPOSING CONDITIONS THAT CAN BE FOUND IN PATHOLOGICAL OR DISEASED MUSCLES: an imbalance in protein synthesis and degradation mechanisms. Thus, we investigated whether exogenous melatonin could regulate muscle components in stroke-induced muscle atrophy in rats. Comparing muscle phenotypes, we found that long-term melatonin administration could influence muscle mass. Muscle atrophy-related genes, including muscle atrophy F-box (MAFbx) and muscle ring finger 1 (MuRF1) were significantly down-regulated in melatonin-administered rats in the gastrocnemius. However, only MAFbx at the mRNA level was attenuated in the soleus of melatonin-administered rats. Insulin-like growth factor-1 receptor (IGF-1R) was significantly over-expressed in melatonin-administered rats in both the gastrocnemius and soleus muscles. Comparing myosin heavy chain (MHC) components, in the gastrocnemius, expression of both slow- and fast-type isoforms were significantly enhanced in melatonin-administered rats. These results suggest that long-term exogenous melatonin-administration may have a prophylactic effect on muscle atrophy through the MuRF1/MAFbx signaling pathway, as well as a potential therapeutic effect on muscle atrophy through the IGF-1-mediated hypertrophic signaling pathway in a stroke animal model.

Keywords: Melatonin; focal cerebral ischemia; muscle atrophy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in muscle mass following melatonin administration for 8 weeks after MCAo. (A) Gastrocnemius, (B) Soleus. Right means to sound side hindlimb. Left means to affected side hindlimb. Rt: right hindlimb; Lt: left hindlimb; Con: control; Veh: MCAo+vehicle; MT7: MCAo+melatonin injection at 7:00; MT19: MCAo+melatonin injection at 19:00; MT7,19: MCAo+melatonin injection at 7:00 and 19:00. **P<0.01 vs. Con.
Figure 2
Figure 2
Morphology of hindlimb muscles following melatonin administration for 8 weeks after MCAo. Veh: MCAo+vehicle; MT7: MCAo+melatonin injection at 7:00; MT19: MCAo+ melatonin injection at 19:00; MT7,19: MCAo+melatonin injection at 7:00 and 19:00. Scale bar=100 µm.
Figure 3
Figure 3
Changes of muscle atrophy- and hypertrophy-related gene expression on stroke-induced muscle atrophy in the gastrocnemius (A) and soleus (B). MT7,19 rats showed inhibition of both MAFbx and MuRF1 mRNA expression and an increase in hypertrophic upstream molecules, such as IGF-1R expression. Con: control; Veh: MCAo+vehicle; MT7: MCAo+ melatonin injection at 7:00; MT19: MCAo+melatonin injection at 19:00; MT7,19: MCAo+melatonin injection at 7:00 and 19:00. (A) **P<0.01 vs. Con; ##P<0.01 vs. Veh. (B) *P<0.05, **P<0.01 vs. Con; #P<0.05, ##P<0.01 vs. Veh.
Figure 4
Figure 4
Changes of MHC components on stroke-induced muscle atrophy in the gastrocnemius (A) and soleus (B). MT7 and MT7,19 rats showed increases in both slow- and fast-type MHC isoforms. Con: control; Veh: MCAo+vehicle; MT7: MCAo+melatonin injection at 7:00; MT19: MCAo+melatonin injection at 19:00; MT7,19: MCAo+melatonin injection at 7:00 and 19:00. (A) *P<0.05, **P<0.01 vs. Con; #P<0.05, ##P<0.01 vs. Veh. (B) *P<0.05, **P<0.01 vs. Con; #P<0.05, ##P<0.01 vs. Veh.
See this image and copyright information in PMC

References

    1. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol. 2004;287(4):C834–C843. - PubMed
    1. Kasper CE, Talbot LA, Gaines JM. Skeletal muscle damage and recovery. AACN Clin Issues. 2002;13(2):237–247. - PubMed
    1. Tischler ME, Henriksen EJ, Munoz KA, Stump CS, Woodman CR, Kirby CR. Spaceflight on STS-48 and earth-based unweighting produce similar effects on skeletal muscle of young rats. J Appl Physiol. 1993;74(5):2161–2165. - PubMed
    1. Zeman RJ, Zhao J, Zhang Y, Zhao W, Wen X, Wu Y, Pan J, Bauman WA, Cardozo C. Differential skeletal muscle gene expression after upper or lower motor neuron transection. Pflugers Arch. 2009;458(3):525–535. - PubMed
    1. Drummond MJ, Glynn EL, Lujan HL, Dicarlo SE, Rasmussen BB. Gene and protein expression associated with protein synthesis and breakdown in paraplegic skeletal muscle. Muscle Nerve. 2008;37(4):505–513. - PMC - PubMed